![Guy, 12 with his father, is the first child to receive an innovative oral treatment for sleeping sickness, in his hometown Mushie in the Democratic Republic of Congo](/optim/dotcom/pages/images/our-company/social-impact/innovation-for-vulnerable-communities/sleeping-sickness_20230522123340.jpg?size=large)
Sleeping Sickness
On December 10, 2020, Sanofi signed a renewed partnership agreement with the World Health Organization to eliminate sleeping sickness by 2030.
![](/optim/dotcom/content-app/articles/social-impact/the-journey-to-eliminate-sleeping-sickness/article16-social-impact-core-image_20230428162733.jpg?size=medium)
The Journey to Eliminate Sleeping Sickness
![](/optim/dotcom/content-app/articles/social-impact/sanofi-and-dndi-breakthrough-on-sleeping-sickness/article11-social-impact-core-image_20230428162928.jpg?size=medium)
Breakthrough on Sleeping Sickness
![](/optim/dotcom/content-app/articles/social-impact/neglected-tropical-diseases/article15-social-impact-core-image_20230428163325.jpg?size=medium)
Burden of Neglected Tropical Diseases Mainly Impacts Underserved Populations
![](/optim/dotcom/pages/images/our-company/social-impact/innovation-for-vulnerable-communities/thumbnail-youtube-my-child-matters-program_20230918164945.jpg?size=large)
Pedriatric Cancers
Sanofi is working to address childhood cancer as a global health issue and to improve survival rates for children with cancer. The Sanofi Corporate Social Responsibility (CSR) Childhood Cancer R&D program focuses on accelerating and developing novel therapies for children with cancer. The philanthropic platform, Foundation S My Child Matters program, is committed to strengthening healthcare and family support for children with cancer in low- and middle-income countries (LMICs).
![](/optim/dotcom/content-app/articles/social-impact/childhood-cancer-r-and-d-program-developing-accelerating-novel-therapies-children-with-cancer/Hero-Banner-R-DProgram-Childhood-Cancer_20240612141610.jpg?size=medium)
Childhood Cancer R&D Program: Developing and Accelerating Novel Therapies for Children With Cancer
![](/optim/dotcom/content-app/articles/social-impact/my-child-matters-improving-childhood-cancer-survival-in-the-developing-world/article17-social-impact-core-image_20230428165941.jpg?size=medium)
My Child Matters: Improving Childhood Cancer Survival in the Developing World
![Paediatric polio vaccination, Edéa regional hospital, Cameroon](/optim/dotcom/pages/images/our-company/social-impact/innovation-for-vulnerable-communities/polio2_20230522123340.jpg?size=large)
Polio
We’re the first global supplier of the injectable polio vaccine and have been fighting to eradicate polio for over 40 years. Since 1988, Sanofi has been a key partner of the Global Polio Eradication Initiative and has supplied billions of doses of Polio Vaccine in the world.
![](https://img.youtube.com/vi/3bSxJHT6ilc/0.jpg)
Journey Towards Polio Eradication Over the Last Decade
References
- https://www.who.int/news-room/fact-sheets/detail/cancer-in-children (Accessed March 2021)
- https://www.who.int/news-room/fact-sheets/detail/cancer-in-children (Accessed on March 2023)
- World Health Organization. (2020). Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. World Health Organization. https://apps.who.int/iris/handle/10665/331452 (Accessed March 2023)